Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Cypress Biosciences Inc (CYPB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2010 Q2 | 0 | 0.00 | Sell 100.00% | 0.17 | SEC | ||
| 2010 Q1 | 2,869,967 | 0.17 | $4.89 | $14,034,000 | SEC | ||
| 2009 Q4 | 2,869,967 | 0.21 | Add 30.48% | 0.05 | $5.77 | $16,560,000 | SEC |
| 2009 Q3 | 2,199,531 | 0.23 | Add 12.82% | 0.03 | $8.17 | $17,970,000 | SEC |
| 2009 Q2 | 1,949,531 | 0.31 | Reduce 42.50% | 0.20 | $9.42 | $18,365,000 | SEC |
| 2009 Q1 | 3,390,528 | 0.48 | Add 0.23% | <0.01 | $7.11 | $24,107,000 | SEC |
| 2008 Q4 | 3,382,588 | 0.51 | Add 6.57% | 0.03 | $6.84 | $23,137,000 | SEC |
| 2008 Q3 | 3,174,176 | 0.30 | Add 0.05% | <0.01 | $7.35 | $23,330,000 | SEC |
| 2008 Q2 | 3,172,476 | 0.22 | Add 19.98% | 0.04 | $7.19 | $22,810,000 | SEC |
| 2008 Q1 | 2,644,249 | 0.21 | Add 122.92% | 0.12 | $7.16 | $18,933,000 | SEC |
| 2007 Q4 | 1,186,185 | 0.14 | Reduce 36.75% | 0.12 | $11.03 | $13,084,000 | SEC |
| 2007 Q2 | 1,875,400 | 0.32 | Add 25.03% | 0.06 | $13.26 | $24,868,000 | SEC |
| 2007 Q1 | 1,500,000 | 0.14 | Reduce 30.05% | 0.07 | $7.60 | $11,400,000 | SEC |
| 2006 Q4 | 2,144,525 | 0.22 | Add 15.91% | 0.03 | $7.75 | $16,620,000 | SEC |
| 2006 Q3 | 1,850,156 | 0.19 | Add 51.53% | 0.06 | $7.30 | $13,506,000 | SEC |
| 2006 Q2 | 1,221,000 | 0.10 | Buy | 0.10 | $6.14 | $7,497,000 | SEC |
| 2004 Q4 | 0 | 0.00 | Sell 100.00% | 0.08 | SEC | ||
| 2004 Q3 | 410,590 | 0.08 | Reduce 52.34% | 0.10 | $11.67 | $4,792,000 | SEC |
| 2004 Q2 | 861,500 | 0.20 | Add 2.44% | <0.01 | $13.73 | $11,828,000 | SEC |
| 2004 Q1 | 841,000 | 0.16 | Buy | 0.16 | $11.50 | $9,672,000 | SEC |